Introduction: The improvement in breast cancer survival rates, along with the expected overdiagnosis and overtreatment associated with breast cancer screening, requires a comprehensive assessment of its burden. Neurological complications can have a devastating impact on these patients; neuropathic pain and chemotherapy-induced peripheral neuropathy are among the most frequently reported. This project aims to understand the burden of neurological complications of breast cancer treatment in Northern Portugal, and their role as mediator of the impact of the treatment in different dimensions of the patients' quality of life. Methods and analysis: A prospective cohort study was designed to include 500 patients with breast cancer, to be followed ...
Background: Chemotherapy induced peripheral neuropathy is a significant disability after the treatme...
Background: Breast cancer is the most common cancer in India, and the number of survivors has increa...
Chemotherapy induced peripheral neuropathy (CIPN) is an adverse effect of taxane-based chemotherapy,...
OBJECTIVES: To quantify the prevalence of neurological complications among breast cancer patients at...
Context: Neuropathic pain (NP) may be an important contributor to the morbidity burden of breast can...
PURPOSE:The purposes of this study were to estimate the incidence of chemotherapy-induced peripheral...
OBJECTIVES: Data regarding the impact of breast cancer treatment-related neuropathic pain (NP) on s...
Purpose To describe the prevalence, severity, and risk factors of chemotherapy-induced peripheral ne...
Abstract Background Many of the 3.8 million breast cancer survivors in the United States experience ...
Background: In the current study, the authors investigated the incidence of moderate to severe chemo...
Introduction: Chemotherapy-induced peripheral neuropathy (CIPN) is a common, dose-limiting effect of...
Breast cancer is the most common cancer among women worldwide, and survival rates are increasing. Ch...
Objective: Chemotherapy-induced peripheral neuropathy (CIPN) presents itself as sensory peripheral n...
Objectives: The objective of this study was to assess the relation between cancer treatments and inc...
Objective. Chemotherapy-induced peripheral neuropathy (CIPN) presents itself as sensory peripheral n...
Background: Chemotherapy induced peripheral neuropathy is a significant disability after the treatme...
Background: Breast cancer is the most common cancer in India, and the number of survivors has increa...
Chemotherapy induced peripheral neuropathy (CIPN) is an adverse effect of taxane-based chemotherapy,...
OBJECTIVES: To quantify the prevalence of neurological complications among breast cancer patients at...
Context: Neuropathic pain (NP) may be an important contributor to the morbidity burden of breast can...
PURPOSE:The purposes of this study were to estimate the incidence of chemotherapy-induced peripheral...
OBJECTIVES: Data regarding the impact of breast cancer treatment-related neuropathic pain (NP) on s...
Purpose To describe the prevalence, severity, and risk factors of chemotherapy-induced peripheral ne...
Abstract Background Many of the 3.8 million breast cancer survivors in the United States experience ...
Background: In the current study, the authors investigated the incidence of moderate to severe chemo...
Introduction: Chemotherapy-induced peripheral neuropathy (CIPN) is a common, dose-limiting effect of...
Breast cancer is the most common cancer among women worldwide, and survival rates are increasing. Ch...
Objective: Chemotherapy-induced peripheral neuropathy (CIPN) presents itself as sensory peripheral n...
Objectives: The objective of this study was to assess the relation between cancer treatments and inc...
Objective. Chemotherapy-induced peripheral neuropathy (CIPN) presents itself as sensory peripheral n...
Background: Chemotherapy induced peripheral neuropathy is a significant disability after the treatme...
Background: Breast cancer is the most common cancer in India, and the number of survivors has increa...
Chemotherapy induced peripheral neuropathy (CIPN) is an adverse effect of taxane-based chemotherapy,...